ArticleFrontiers in pharmacology2026

Cardiovascular toxicity of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in HR+/HER2- breast cancer: a real-world study based on the FAERS database.

Shuai Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.